BioSpace News Archive

Drug Development

Basilea announces completion of patient enrolment in phase 3 ERADICATE study investigating ceftobiprole in bloodstream infections

Basilea Pharmaceutica Ltd., a commercial-stage biopharmaceutical company committed to meeting the needs of patients with infectious diseases and cancer, announced the completion of patient enrolment into the phase 3 ERADICATE study.

January 11, 2022
·
5 min read
Job Trends

Evotec Expands Neuroscience Collaboration with Bristol Myers Squibb to Include New Targeted Protein Degradation Approach

Evotec SE announced that the Company has expanded its neurodegeneration collaboration with Bristol Myers Squibb with the initiation of discovery and development efforts regarding a new strategy to tackle neurodegenerative diseases including Alzheimer’s through a novel approach to targeted protein degradation.

January 11, 2022
·
4 min read
MOTUS CONSUMER INSIGHTS ANNOUNCES STRATEGIC INVESTMENT

Motus Consumer Insights today announced that it has completed a round of strategic investments, led by DTR Investments.

January 11, 2022
·
1 min read
Intrivo’s On/Go COVID-19 rapid self-test ranked No. 1 among seven leading tests by an independent patient safety group for ease of use, simplicity and quality of digital technology, as the On/Go mobile app tops Apple App Store medical chart

Intrivo’s On/Go COVID-19 rapid self-test is named the most user-friendly among antigen home tests by ECRI, an independent healthcare quality and safety organization.

January 11, 2022
·
3 min read
Biotech Beach

Renovo Solutions Receives Growth Investment from Water Street Healthcare Partners

Health Care & Life Sciences Technology Management Company to Expand Offering; Recruits Seasoned Health Care Executive to Spearhead Expansion.

January 11, 2022
·
4 min read
Genetown

Verastem Oncology Outlines Key 2022 Strategic Priorities and Upcoming Catalysts for Advancing VS-6766 as a Backbone of Therapy for RAS Pathway-Driven Cancers

Verastem Oncology today outlined key strategic priorities and upcoming catalysts to support its lead compound VS-6766 in 2022.

January 11, 2022
·
9 min read
NeoGenomics Announces RaDaR(TM) Assay Receives CE Mark and is Submitted for US Reimbursement via the MolDX Program

NeoGenomics, Inc. today announced that its liquid biopsy focused subsidiary Inivata Limited has received the CE mark for its RaDa assay for the detection of molecular residual disease (MRD) and recurrence, having met the requirements of the European In-Vitro Diagnostics Directive (98/79/EC).

January 11, 2022
·
7 min read
Business

GSK and Vir Biotechnology Announce United States Government Agreement to Purchase Additional Supply of Sotrovimab, Authorized for the Early Treatment of COVID-19

GlaxoSmithKline plc (LSE/NYSE: GSK) and Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that the US government will purchase an additional 600,000 doses of sotrovimab, an investigational monoclonal antibody for the early treatment of COVID-19, enabling further nationwide access to sotrovimab for patients.

January 11, 2022
·
16 min read
New Peripheral Vascular Microcatheters Save Procedure Time and Advance Treatment Capabilities

Transit Scientific announced continued multicenter success with the XO Cross ® platform.

January 11, 2022
·
2 min read
Galmed Continues to Drive Innovation with Three New US Patents Granted for Aramchol and its Meglumine Salt

Galmed Pharmaceuticals Ltd. announced today that the United States Patent and Trademark Office (USPTO) granted Galmed new patents related to the use of Aramchol for the treatment of fibrosis and for the treatment for modulating gut microbiota.

January 11, 2022
·
5 min read